These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
106 related items for PubMed ID: 10504376
21. Aberrant expression of 5-lipoxygenase-activating protein (5-LOXAP) has prognostic and survival significance in patients with breast cancer. Jiang WG, Douglas-Jones AG, Mansel RE. Prostaglandins Leukot Essent Fatty Acids; 2006 Feb; 74(2):125-34. PubMed ID: 16364620 [Abstract] [Full Text] [Related]
22. Vascular endothelial growth factors C and D represent novel prognostic markers in colorectal carcinoma using quantitative image analysis. Hu WG, Li JW, Feng B, Beveridge M, Yue F, Lu AG, Ma JJ, Wang ML, Guo Y, Jin XL, Zheng MH. Eur Surg Res; 2007 Feb; 39(4):229-38. PubMed ID: 17446709 [Abstract] [Full Text] [Related]
23. Telomerase as a prognostic marker in breast cancer: high-throughput tissue microarray analysis of hTERT and hTR. Poremba C, Heine B, Diallo R, Heinecke A, Wai D, Schaefer KL, Braun Y, Schuck A, Lanvers C, Bànkfalvi A, Kneif S, Torhorst J, Zuber M, Köchli OR, Mross F, Dieterich H, Sauter G, Stein H, Fogt F, Boecker W. J Pathol; 2002 Oct; 198(2):181-9. PubMed ID: 12237877 [Abstract] [Full Text] [Related]
24. ATBF1-a messenger RNA expression is correlated with better prognosis in breast cancer. Zhang Z, Yamashita H, Toyama T, Sugiura H, Ando Y, Mita K, Hamaguchi M, Kawaguchi M, Miura Y, Iwase H. Clin Cancer Res; 2005 Jan 01; 11(1):193-8. PubMed ID: 15671546 [Abstract] [Full Text] [Related]
25. E-cadherin expression in invasive non-lobular carcinoma of the breast and its prognostic significance. Rakha EA, Abd El Rehim D, Pinder SE, Lewis SA, Ellis IO. Histopathology; 2005 Jun 01; 46(6):685-93. PubMed ID: 15910600 [Abstract] [Full Text] [Related]
26. Apolipoprotein D predicts adverse outcome in women >or=70 years with operable breast cancer. Søiland H, Janssen EA, Kørner H, Varhaug JE, Skaland I, Gudlaugsson E, Baak JP, Søreide JA. Breast Cancer Res Treat; 2009 Feb 01; 113(3):519-28. PubMed ID: 18330697 [Abstract] [Full Text] [Related]
27. The role of STS and OATP-B mRNA expression in predicting the clinical outcome in human breast cancer. Al Sarakbi W, Mokbel R, Salhab M, Jiang WG, Reed MJ, Mokbel K. Anticancer Res; 2006 Feb 01; 26(6C):4985-90. PubMed ID: 17214375 [Abstract] [Full Text] [Related]
28. Elevated expression of cyclooxygenase-2 is a negative prognostic factor for disease free survival and overall survival in patients with breast carcinoma. Denkert C, Winzer KJ, Müller BM, Weichert W, Pest S, Köbel M, Kristiansen G, Reles A, Siegert A, Guski H, Hauptmann S. Cancer; 2003 Jun 15; 97(12):2978-87. PubMed ID: 12784332 [Abstract] [Full Text] [Related]
29. Intramammary lymph node metastases are an independent predictor of poor outcome in patients with breast carcinoma. Shen J, Hunt KK, Mirza NQ, Krishnamurthy S, Singletary SE, Kuerer HM, Meric-Bernstam F, Feig B, Ross MI, Ames FC, Babiera GV. Cancer; 2004 Sep 15; 101(6):1330-7. PubMed ID: 15316905 [Abstract] [Full Text] [Related]
30. Tissue microarray analysis of signal transducers and activators of transcription 3 (Stat3) and phospho-Stat3 (Tyr705) in node-negative breast cancer shows nuclear localization is associated with a better prognosis. Dolled-Filhart M, Camp RL, Kowalski DP, Smith BL, Rimm DL. Clin Cancer Res; 2003 Feb 15; 9(2):594-600. PubMed ID: 12576423 [Abstract] [Full Text] [Related]
31. Prognostic significance of glutathione S-transferase-pi in invasive breast cancer. Huang J, Tan PH, Thiyagarajan J, Bay BH. Mod Pathol; 2003 Jun 15; 16(6):558-65. PubMed ID: 12808061 [Abstract] [Full Text] [Related]
32. Long-term prognostic significance of HER-2/neu in untreated node-negative breast cancer depends on the method of testing. Schmidt M, Lewark B, Kohlschmidt N, Glawatz C, Steiner E, Tanner B, Pilch H, Weikel W, Kölbl H, Lehr HA. Breast Cancer Res; 2005 Jun 15; 7(2):R256-66. PubMed ID: 15743506 [Abstract] [Full Text] [Related]
33. High MMP-1 mRNA expression is a risk factor for disease-free and overall survivals in patients with invasive breast carcinoma. Cheng S, Tada M, Hida Y, Asano T, Kuramae T, Takemoto N, Hamada J, Miyamoto M, Hirano S, Kondo S, Moriuchi T. J Surg Res; 2008 May 01; 146(1):104-9. PubMed ID: 17663001 [Abstract] [Full Text] [Related]
34. The expression of ER beta protein correlates with vascular endothelial growth factor and its prognostic significance in human breast cancer. Wen XF, Shen Z, Shen ZZ, Nguyen M, Shao ZM. Oncol Rep; 2002 May 01; 9(5):937-44. PubMed ID: 12168051 [Abstract] [Full Text] [Related]
35. Detection of isolated tumor cells in bone marrow is an independent prognostic factor in breast cancer. Wiedswang G, Borgen E, Kåresen R, Kvalheim G, Nesland JM, Qvist H, Schlichting E, Sauer T, Janbu J, Harbitz T, Naume B. J Clin Oncol; 2003 Sep 15; 21(18):3469-78. PubMed ID: 12972522 [Abstract] [Full Text] [Related]
36. Enhanced prediction of breast cancer prognosis by evaluating expression of p53 and prostate-specific antigen in combination. Yu H, Levesque MA, Clark GM, Diamandis EP. Br J Cancer; 1999 Oct 15; 81(3):490-5. PubMed ID: 10507775 [Abstract] [Full Text] [Related]
37. [Expression of c-erbB2 protein and its relation to prognosis in 284 primary breast cancer patients]. Yang LF, Song ST, Li XB, Jiang ZF, Liu XQ, Ma WN, Jiao XP, Guo SQ. Zhonghua Zhong Liu Za Zhi; 2006 Apr 15; 28(4):294-7. PubMed ID: 16875632 [Abstract] [Full Text] [Related]
38. Prognostic significance of the metastasis-associated protein osteopontin in human breast cancer. Rudland PS, Platt-Higgins A, El-Tanani M, De Silva Rudland S, Barraclough R, Winstanley JH, Howitt R, West CR. Cancer Res; 2002 Jun 15; 62(12):3417-27. PubMed ID: 12067984 [Abstract] [Full Text] [Related]
39. Significance of intramammary lymph nodes in the staging of breast cancer: correlation with tumor characteristics and outcome. Nassar A, Cohen C, Cotsonis G, Carlson G. Breast J; 2008 Jun 15; 14(2):147-52. PubMed ID: 18248563 [Abstract] [Full Text] [Related]
40. Morphological and immunophenotypic analysis of breast carcinomas with basal and myoepithelial differentiation. Rakha EA, Putti TC, Abd El-Rehim DM, Paish C, Green AR, Powe DG, Lee AH, Robertson JF, Ellis IO. J Pathol; 2006 Mar 15; 208(4):495-506. PubMed ID: 16429394 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]